CLINICAL STUDY TO INVESTIGATE THE EFFICACY, PHARMACOKINETICS, IMMUNOGENICITY AND SAFETY OF WILATE IN SEVERE VON WILLEBRAND DISEASE PATIENTS UNDER THE AGE OF 6 YEARS

Registry ID

WIL-33

Source registry

HEALTH_CANADA

Status

Pending

Study type

INTERVENTIONAL

Sponsor

OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H

Last update

2022-08-31

Conditions

• VON WILLEBRAND DISEASE

Related clinical trials

• A PHASE III, MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH TYPE 3 VON WILLEBRAND DISEASE
• A SAFETY, TOLERABILITY, PHARMACOKINETIC, AND PHARMACODYNAMIC STUDY OF VGA039 FOLLOWING INTRAVENOUS OR SUBCUTANEOUS ADMINISTRATION OF SINGLE ASCENDING DOSES IN HEALTHY ADULTS AND ADULT PATIENTS WITH VON WILLEBRAND DISEASE

View on source registry